Clinical Trial Update: Nasopharyngeal Streptococcus Pneumoniae Carriage

View source ↗

Summary

Pfizer reports that a trial studying nasopharyngeal carriage of Streptococcus pneumoniae has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Snippet

Sponsor: Pfizer | Conditions: Streptococcus Pneumoniae Infections | Status: COMPLETED | Results posted: 2013-11-20